US lawmakers reveal policy to curb collaboration with Chinese biotech
If enacted, lawmakers will hold the right to monitor and restrict American companies from signing certain deals with Chinese entities.
If enacted, lawmakers will hold the right to monitor and restrict American companies from signing certain deals with Chinese entities.
Strong systems that enable trust and governance are key to enabling the growth of AI technologies in drug development.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Advancing pressure protection in biopharma: how integrated bypass technology elevates single-use pump design
CinnaGen Enters EU Market with EMA Approval for Zandoriah®
Eli Lilly and NVIDIA to build pharma’s “most powerful” supercomputer
Huawei’s three key steps to drive industrial intelligence forward and unleash AI’s full potential